Average cost of multi drug-resistant tuberculosis treatment in Kenya
Kenya: Average cost of multi drug-resistant tuberculosis treatment was 1,800 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
1,800 constant 2022 US$
Change on year
unchanged
World rank
26th
of 92 countries
All-time high
3,300 constant 2022 US$
in 2019
All-time low
1,499 constant 2022 US$
in 2021
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Kenya, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of multi drug-resistant tuberculosis treatment in Kenya stood at 1,800 constant 2022 US$.
The figure is down 23.4% over ten years.
That places Kenya 26th out of 92 countries with data for 2024, putting it in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Kenya, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,350 constant 2022 US$ | — |
| 2018 | 3,000 constant 2022 US$ | +27.7% |
| 2019 | 3,300 constant 2022 US$ | +10.0% |
| 2020 | 1,805 constant 2022 US$ | -45.3% |
| 2021 | 1,499 constant 2022 US$ | -17.0% |
| 2022 | 1,628 constant 2022 US$ | +8.6% |
| 2023 | 1,800 constant 2022 US$ | +10.6% |
| 2024 | 1,800 constant 2022 US$ | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,883 constant 2022 US$ | 2,350 constant 2022 US$ | 3,300 constant 2022 US$ | 3 |
| 2020s | 1,706 constant 2022 US$ | 1,499 constant 2022 US$ | 1,805 constant 2022 US$ | 5 |
Countries ranked near Kenya
- 24 Ukraine 1,994 constant 2022 US$ compare
- 25 Thailand 1,823 constant 2022 US$ compare
- 27 Tanzania, United Republic of 1,729 constant 2022 US$ compare
- 28 Dominican Republic 1,650 constant 2022 US$ compare
- 29 Kyrgyzstan 1,607 constant 2022 US$ compare
More health data for Kenya
- Un projection of annual infant deaths, annual growth rate -1.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6026 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,119 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,059 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.3381 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.18 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.3574 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1826 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Kenya?
- Average cost of multi drug-resistant tuberculosis treatment in Kenya was 1,800 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Kenya?
- The highest recorded value was 3,300 constant 2022 US$ in 2019.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Kenya?
- The lowest recorded value was 1,499 constant 2022 US$ in 2021.
- How does Kenya rank for average cost of multi drug-resistant tuberculosis treatment?
- Kenya ranks 26th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Kenya?
- Over the last ten years it is down 23.4%. The long-run trend across the full record is falling.
- Where does this Kenya data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.